3652 results for «355»
3652 results
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
TAVI with a new generation of valve and difficult arterial access - LIVE case
07 Dec 2023 – From GulfPCR-GIM 2023
An 84-year-old woman with type 2 diabetes, anaemia (Hgb: 9 g/dl), morbid obesity and limited mobility, and mild LV function impairment (50%), presented an acute heart failure on severe aortic valve stenosis.
The operators decided to implant an Evolut FX by femoral access with secondary access in...
Lifetime management - Tailoring treatment options to secure future possibilities
07 Dec 2023 – From GulfPCR-GIM 2023
Discover key insights in this video session from GulfPCR-GIM 2023 focusing on post-TAVI considerations. Gain understanding into the importance of posterior left ventricular and conduction disorders after TAVI and their impact on long-term outcomes. Explore the latest evidence regarding lifetime management for aortic stenosis patients. Delve...
Left main stenting: one vs. two stent strategy
06 Dec 2023 – From GulfPCR-GIM 2023
In these selected clinical cases, discover strategies on whether to choose one or two stents in the case of left main disease. Explore the use of effective imaging, IABP, and other mechanical support devices.
Challenging cases – Best case submissions
07 Dec 2023 – From GulfPCR-GIM 2023
Explore catheter intervention for mechanical valve thrombosis, understand severe chest pain and shock in a young female patient, discover iatrogenic left main coronary artery type F dissection, address refractory ascites transitioning from internal medicine to interventional cardiology, and witness a narrowly avoided rotablation nightmare in this...
GulfPCR-GIM 2023 Closing Ceremony
07 Dec 2023 – From GulfPCR-GIM 2023
There is no better way to close this 2023 edition of GulfPCR-GIM than to start by thanking the clinical case and abstract authors for their submissions, before revealing the best ones and rewarding the winners. Then it's time to review this year's event by presenting the key...
Tailored approaches to complex bifurcation PCI: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
This session focuses on PCI approaches to complex bifurcation. Learn more about the use of TAP technique, provisional stenting in a trifurcation, and complex multivessel PCI through the lens of a selection of cases.
Rapid-fire - Nightmares in the cathlab - Part 3
21 Nov 2023 – From PCR London Valves 2023
Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
Top Interventional Trials presented at ACC.21
07 Jun 2021
Ali Nazmi Calik provides a summary and key take-aways and infographics of 9 major trials of interest to interventional cardiologists presented at ACC.21
Author
